Navigation Links
NC Biomanufacturers Supply Defense for World vs. Flu
Date:4/29/2009

Huge GSK, Novartis, Merck plants help define state's economic successes

RESEARCH TRIANGLE PARK, N.C., April 29 /PRNewswire-USNewswire/ -- The global fight against swine flu is shining a spotlight on North Carolina's long-term commitment to biomanufacturing.

Global pharmaceutical giant GlaxoSmithKline, with North American headquarters in Research Triangle Park, is one of the world's two key manufacturers of antiviral flu treatments. GSK makes Relenza at its plant in Zebulon, about 25 miles east of its headquarters campus.

GSK and Swiss drug company Roche, which makes Tamiflu, have notified the World Health Organization that this new strain of the swine-flu virus seems to respond to their medicines.

"When we're called upon to tackle these kinds of disease outbreaks, North Carolina's excellent base of medical research and pharmaceutical manufacturing puts us among global leaders," said E. Norris Tolson, president and CEO of the North Carolina Biotechnology Center.

North Carolina has invested $1.2 billion in steady bioscience growth during the past decade, said Tolson. "Some states aren't so interested in manufacturing. But at times like these, it becomes clear why these science-driven factories are so crucial."

Hundreds of workers at GSK's Zebulon factory have made medicines to supply the world for more than two decades. Meanwhile, Novartis has a flu-vaccine plant under construction at the edge of Holly Springs, about 20 miles southwest of Raleigh.

Read the full story online.

The Biotechnology Center is a private, non-profit corporation supported by the N.C. General Assembly. Its mission is to provide long-term economic and societal benefits to North Carolina by supporting biotechnology research, business, education and strategic policy statewide.

Contact: Chris Brodie, vice president of corporate communications, North Carolina Biotechnology Center, chris_brodie@ncbiotech.org or 919-541-9366. Visit the Biotechnology Center's Web site at www.ncbiotech.org.


'/>"/>
SOURCE North Carolina Biotechnology Center
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Hospira Names Brian Meadows Supply Chain Chief
2. Oxygen Biotherapeutics, Inc. Signs Supply Agreement for Clinical-Grade Oxycyte for Clinical Trials and Future Needs
3. Sigma-Aldrich Enters Exclusive Supply Agreement With Gene Oracle to Leverage Its Unique GeneIOS Gene Synthesis Platform
4. New Generation Biofuels Signs Sales Contract with Catoctin Mountain Growers to Supply up to 370,000 gallons of Renewable Biofuel
5. Norgen Biotek Corp. Announces OEM Manufacturing & Supply Agreement with Exiqon A/S
6. SurgiQuest Signs a Development and Supply Agreement with Intuitive Surgical for MIS Access Utilizing the AirSeal(TM) Technology
7. ProMetic signs $35 M Long-term Supply Agreement with European Biopharmaceutical company
8. ConjuChem and Novozymes Enter Long-Term Supply Agreement for Recombumin(R) use in PC-DAC(TM):Exendin-4
9. Poniard Pharmaceuticals Announces Commercial Supply Agreement for Picoplatin
10. Wyeth Names Michael Kamarck President, Technical Operations & Product Supply
11. Health Robotics Announces Contract for its CytoCare(TM) and IV Station(TM) Robots With Arabian Health Care Supply Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... , Feb. 24, 2017  OncoSec Medical Incorporated ("OncoSec") ... will host a Key Opinion Leader event to highlight ... oral and poster presentation at the upcoming 2017 ASCO-SITC ... KOL event will be held in-person and via live ... / 9:00 AM PST at the Lotte New York ...
(Date:2/23/2017)... - The Fight Against Cancer Innovation Trust (FACIT) and ... to report that Fusion Pharmaceuticals Inc. (Fusion) has closed ... Innovation – JJDC, Inc. (JJDC) as the lead investor. ... Partners, and Genesys Capital, as well as founding investor ... ...
(Date:2/23/2017)... Minn. , Feb. 23, 2017  Imanis ... new product line of oncolytic vaccinia viruses for ... Corporation as part of Genelux,s proprietary, vaccinia virus-based ... are excited to enter into a partnership with ... selected oncolytic vaccinia viruses for use in research," ...
(Date:2/23/2017)... , ... February 23, 2017 , ... ... (such as insulin, cortisol, CRP, adiponectin, uric acid, and/or other biomarkers or SNPs ... Insulin Assay from Salimetrics’ SalivaLab , the relationship between insulin and other ...
Breaking Biology Technology:
(Date:2/3/2017)... 2017 A new independent identity strategy consultancy ... (IdSP) . Designed to fill a critical niche in ... founding partners Mark Crego and Janice ... in identity expertise that span federal governments, the 9/11 ... Crego-Kephart combined expertise has a common theme born from ...
(Date:2/1/2017)... -- IDTechEx Research, a leading provider of independent market ... of a new report, Sensors for Robotics: Technologies, Markets and ... ... ... Report "Sensors for Robotics: Technologies, Markets and Forecasts 2017-2027: Machine vision, ...
(Date:1/26/2017)...  Acuity Market Intelligence today released the 2017 ...  Acuity characterizes 2017 as a "breakout" year for ... a new understanding of the potential benefits these ... identity are often perceived as threats to privacy ... of Acuity Market intelligence. "However, taken together these ...
Breaking Biology News(10 mins):